ArticleBone marrow transplantation2013

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma.

R Crocchiolo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.